Danny Chi Yeu Leung received his B.Sc. in Human Genetics from University College London and his M.Sc. in Human Molecular Genetics from Imperial College London. He subsequently conducted his Ph.D. research at the University of British Columbia, where he began to delve into the field of epigenetics. He then conducted a post-doctoral fellowship at the Ludwig Institute for Cancer Research in San Diego. He was a California Institute of Regenerative Medicine fellow and the project manager of the San Diego branch of the NIH Roadmap Epigenomics Project. He was the recipient of the 2017 Croucher Innovation Award. He is currently an associate professor at the Hong Kong University of Science and Technology. His laboratory’s research focuses on the interplay between epigenetic pathways in the regulation of non-coding DNA. He serves as the director for the HKUST Center for Epigenomics Research and the lead investigator of the Hong Kong Epigenomics Project.
Danny Chi Yeu Leung received his B.Sc. in Human Genetics from University College London and his M.Sc. in Human Molecular Genetics from Imperial College London. He subsequently conducted his Ph.D. research at the University of British Columbia, where he began to delve into the field of epigenetics. He then conducted a post-doctoral fellowship at the Ludwig Institute for Cancer Research in San Diego. He was a California Institute of Regenerative Medicine fellow and the project manager of the San Diego branch of the NIH Roadmap Epigenomics Project. He was the recipient of the 2017 Croucher Innovation Award. He is currently an associate professor at the Hong Kong University of Science and Technology. His laboratory’s research focuses on the interplay between epigenetic pathways in the regulation of non-coding DNA. He serves as the director for the HKUST Center for Epigenomics Research and the lead investigator of the Hong Kong Epigenomics Project.